Discontinuation of imatinib in patients with oligo-metastatic gastrointestinal stromal tumor who are in complete radiological remission: A prospective multicenter phase II study.

被引：0
作者：
Hompland, Ivar
Boye, Kjetil
Papakonstantinou, Andri
Rosok, Bard
Joensuu, Heikki
Bruland, Oyvind
机构：
[1] Oslo Univ Hosp, Oslo, Norway
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Univ Helsinki, Cent Hosp, Helsinki, Finland
[4] Oncoinvent AS, Oslo, Norway
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11535
引用
收藏
页数：1
相关论文
共 50 条
[41]   Survival of elderly patients with advanced gastrointestinal stromal tumor in pre- and post-imatinib era: A population-based study. [J].
Basnet, Bibhusan ;
Khanal, Amit ;
Uprety, Dipesh ;
Bista, Amir ;
Agarwal, Deepak ;
Shah, Binay Kumar .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[42]   Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study [J].
Savas, Emine Merve ;
Yilmaz, Seda ;
Dikyar, Ayse Asena Baser ;
Ozkurt, Zubeyde Nur ;
Ocal, Ramazan ;
Can, Ferda ;
Pepeler, Sezgin ;
Kaynar, Lale Aydin ;
Gokcen, Sanem ;
Yildiz, Abdulkerim ;
Albayrak, Murat ;
Karakus, Sema ;
Ceneli, Ozcan ;
Yagci, Munci .
TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 (04) :236-241
[43]   A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17 [J].
Yeh, Chun-Nan ;
Chen, Ming-Huang ;
Chen, Yen-Yang ;
Yang, Ching-Yao ;
Yen, Chueh-Chuan ;
Tzen, Chin-Yuan ;
Chen, Li-Tzong ;
Chen, Jen-Shi .
ONCOTARGET, 2017, 8 (27) :44121-44130
[44]   Randomized phase III trial of imatinib (IM) rechallenge versus placebo in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) after failure of at least both IM and sunitinib (SU): Right study. [J].
Kang, Yoon-Koo ;
Ryu, Min-Hee ;
Ryoo, Baek-Yeol ;
Kim, Hyun Jin ;
Lee, Jong Jin ;
Yoo, Changhoon ;
Nam, Byung-Ho ;
Ramaiya, Nikhil ;
Jagannathan, Jyothi Priya ;
Demetri, George D. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[45]   Masatinib mesylate in imatinib-naive locally advanced or metastatic gastrointestinal stromal tumor (GIST): Results of the French Sarcoma Group phase II trial [J].
Le Cesne, A. ;
Blay, J. ;
Bui, N. B. ;
Bouche, O. ;
Adenis, A. ;
Domont, J. ;
Cioffi, A. ;
Moussy, A. ;
Hermine, O. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[46]   Complete Longitudinal Analyses of the Randomized, Placebo-Controlled, Phase III Trial of Sunitinib in Patients with Gastrointestinal Stromal Tumor following Imatinib Failure [J].
Demetri, George D. ;
Garrett, Christopher R. ;
Schoffski, Patrick ;
Shah, Manisha H. ;
Verweij, Jaap ;
Leyvraz, Serge ;
Hurwitz, Herbert I. ;
Lopez Pousa, Antonio ;
Le Cesne, Axel ;
Goldstein, David ;
Paz-Ares, Luis ;
Blay, Jean-Yves ;
McArthur, Grant A. ;
Xu, Qiang ;
Huang, Xin ;
Harmon, Charles S. ;
Tassell, Vanessa ;
Cohen, Darrel P. ;
Casali, Paolo G. .
CLINICAL CANCER RESEARCH, 2012, 18 (11) :3170-3179
[47]   A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor [J].
Pantaleo, Maria A. ;
Heinrich, Michael C. ;
Italiano, Antoine ;
Valverde, Claudia ;
Schoffski, Patrick ;
Grignani, Giovanni ;
Reyners, Anna K. L. ;
Bauer, Sebastian ;
Reichardt, Peter ;
Stark, Daniel ;
Berhanu, Ghimja ;
Brandt, Ulrike ;
Stefanelli, Tommaso ;
Gelderblom, Hans .
BMC CANCER, 2022, 22 (01)
[48]   Results of Phase II trial of AUY922, a novel heat shock protein inhibitor in patients with metastatic gastrointestinal stromal tumor (GIST) and imatinib and sunitinib therapy. [J].
Chiang, Nai-Jung ;
Yeh, Kun-Huei ;
Chiu, Chang-Fang ;
Chen, Jen-Shi ;
Yen, Chueh-Chuan ;
Lee, Kuan-Der ;
Lin, Yu-Lin ;
Bai, Li-Yuan ;
Chen, Ming-Huang ;
Lin, Jen-Shi ;
Yang, Youngsen ;
Rau, Kun-Ming ;
Hsiao, Hui-Hua ;
Shan, Yan-Shen ;
Chen, Li-Tzong .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
[49]   Efficacy and safety of ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: A phase 2 multicenter, randomized, openlabel study in China. [J].
Li, Jian ;
Zhang, Jun ;
Zhang, Yanqiao ;
Qiu, Haibo ;
Zhou, Yanbing ;
Zhou, Yongjian ;
Zhang, Xinhua ;
Zhou, Ye ;
Zhu, Yuping ;
Li, Yong ;
Wang, Ming ;
Shen, Kuntang ;
Tao, Kaixiong ;
Wu, Xin ;
Wang, Haijiang ;
Zhang, Bo ;
Ling, Jiayu ;
Ye, Yingjiang ;
Dong, Juan ;
Shen, Lin .
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 :803-803
[50]   A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor [J].
Maria A. Pantaleo ;
Michael C. Heinrich ;
Antoine Italiano ;
Claudia Valverde ;
Patrick Schöffski ;
Giovanni Grignani ;
Anna K. L. Reyners ;
Sebastian Bauer ;
Peter Reichardt ;
Daniel Stark ;
Ghimja Berhanu ;
Ulrike Brandt ;
Tommaso Stefanelli ;
Hans Gelderblom .
BMC Cancer, 22
12345